What is Legal Insider Trading? How do I use this site?
Learn More ›
Login/Signup
Top Companies
Form Screener
Random Insider
Random Company
Sectors
FAQ
Feedback
Blog
Pricing
iTeos Therapeutics, Inc. (ITOS)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
Date
Insider
Company
Owned Shares
Shares Traded
Price
Net Total
SELL
8 Jun 2022
Hallal David
Director
iTeos Therapeutics, Inc.
(ITOS)
0
-100%
29,615
$20.17
$597,213.56
SELL
9 May 2022
Davis Aaron I.
Director
iTeos Therapeutics, Inc.
(ITOS)
2,491,167
-21%
663,000
$21.04
$13,949,234.00
SELL
28 Apr 2022
Davis Aaron I.
Director
iTeos Therapeutics, Inc.
(ITOS)
2,909,758
-11%
375,000
$27.33
$10,247,870.00
SELL
18 Apr 2022
Detheux Michel
Chief Executive Officer, Officer
iTeos Therapeutics, Inc.
(ITOS)
26,296
-30%
11,500
$31.87
$366,530.44
BUY
22 Mar 2022
Davis Aaron I.
Director
iTeos Therapeutics, Inc.
(ITOS)
3,192,058
+1%
50,000
$32.51
$1,625,488.80
SELL
21 Mar 2022
Detheux Michel
Chief Executive Officer, Officer
iTeos Therapeutics, Inc.
(ITOS)
38,878
-32%
18,437
$34.17
$629,987.06
SELL
17 Mar 2022
Boxer Capital, LLC
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
3,142,058
-15%
575,201
$35.25
$20,275,836.00
SELL
11 Mar 2022
Lager Joanne Jenkins
Chief Medical Officer, Officer
iTeos Therapeutics, Inc.
(ITOS)
0
-100%
3,500
$36.01
$126,034.99
SELL
1 Mar 2022
McGrath Yvonne
Chief Scientific Officer, Officer
iTeos Therapeutics, Inc.
(ITOS)
0
-100%
10,000
$36.76
$367,570.00
SELL
23 Feb 2022
Detheux Michel
Chief Executive Officer, Officer
iTeos Therapeutics, Inc.
(ITOS)
35,244
-29%
14,500
$34.34
$497,904.88
SELL
11 Feb 2022
Lager Joanne Jenkins
Chief Medical Officer, Officer
iTeos Therapeutics, Inc.
(ITOS)
1,518
-69%
3,500
$35.85
$125,458.50
SELL
25 Jan 2022
Detheux Michel
Chief Executive Officer, Officer
iTeos Therapeutics, Inc.
(ITOS)
53,612
-21%
14,500
$35.68
$517,378.12
SELL
14 Jan 2022
Lager Joanne Jenkins
Chief Medical Officer, Officer
iTeos Therapeutics, Inc.
(ITOS)
723
-82%
3,500
$39.32
$137,613.60
SELL
4 Jan 2022
MPM BioVentures 2014, L.P.
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
2,738,785
-5%
146,685
$42.58
$6,246,049.50
SELL
4 Jan 2022
GADICKE ANSBERT
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
4,484,728
-5%
245,469
$42.58
$10,452,334.00
SELL
4 Jan 2022
MPM BIOVENTURES 2018, L.P.
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
2,738,785
-5%
146,685
$42.58
$6,246,049.50
SELL
3 Jan 2022
Lager Joanne Jenkins
Chief Medical Officer, Officer
iTeos Therapeutics, Inc.
(ITOS)
0
-100%
7,000
$51.90
$363,300.00
SELL
3 Jan 2022
Boxer Capital, LLC
Director, 10% Owner
iTeos Therapeutics, Inc.
(ITOS)
3,767,405
-15%
700,000
$46.54
$32,575,644.00
SELL
3 Jan 2022
Biniszkiewicz Detlev
Director
iTeos Therapeutics, Inc.
(ITOS)
0
-100%
3,500
$51.90
$181,650.00
SELL
27 Dec 2021
Gall Matthew
Chief Financial Officer, Officer
iTeos Therapeutics, Inc.
(ITOS)
14,429
-25%
5,000
$46.45
$232,250.00
SELL
20 Dec 2021
Hallal David
Director
iTeos Therapeutics, Inc.
(ITOS)
0
-100%
50,000
$43.57
$2,178,500.00
SELL
17 Dec 2021
Lager Joanne Jenkins
Chief Medical Officer, Officer
iTeos Therapeutics, Inc.
(ITOS)
0
-100%
7,000
$41.00
$287,000.00
SELL
10 Dec 2021
Lager Joanne Jenkins
Chief Medical Officer, Officer
iTeos Therapeutics, Inc.
(ITOS)
0
-100%
3,500
$34.50
$120,750.00
SELL
3 Dec 2021
MPM BioVentures 2014, L.P.
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
2,886,964
-1%
49,831
$33.73
$1,680,611.10
SELL
3 Dec 2021
GADICKE ANSBERT
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
4,732,696
-1%
83,390
$33.73
$2,812,427.50
SELL
3 Dec 2021
MPM BIOVENTURES 2018, L.P.
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
2,886,964
-1%
49,831
$33.73
$1,680,611.10
SELL
2 Dec 2021
Detheux Michel
Chief Executive Officer, Officer
iTeos Therapeutics, Inc.
(ITOS)
78,349
-36%
44,500
$44.54
$1,982,131.20
SELL
30 Nov 2021
MPM BioVentures 2014, L.P.
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
2,942,731
-2%
83,519
$34.47
$2,878,562.50
SELL
30 Nov 2021
GADICKE ANSBERT
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
4,826,021
-2%
139,773
$34.47
$4,817,417.00
SELL
30 Nov 2021
MPM BIOVENTURES 2018, L.P.
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
2,942,731
-2%
83,519
$34.47
$2,878,562.50
SELL
26 Nov 2021
MPM BioVentures 2014, L.P.
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
3,019,118
-0%
23,045
$35.18
$810,765.75
SELL
26 Nov 2021
GADICKE ANSBERT
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
4,953,860
-0%
38,566
$35.18
$1,356,825.00
SELL
26 Nov 2021
MPM BIOVENTURES 2018, L.P.
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
3,019,118
-0%
23,045
$35.18
$810,765.75
SELL
22 Nov 2021
Detheux Michel
Chief Executive Officer, Officer
iTeos Therapeutics, Inc.
(ITOS)
78,200
-15%
14,500
$36.08
$523,160.03
SELL
18 Nov 2021
Lager Joanne Jenkins
Chief Medical Officer, Officer
iTeos Therapeutics, Inc.
(ITOS)
0
-100%
28,000
$34.50
$966,000.00
SELL
17 Nov 2021
MPM BioVentures 2014, L.P.
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
3,073,334
-2%
77,455
$36.61
$2,835,263.00
SELL
17 Nov 2021
GADICKE ANSBERT
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
5,044,587
-2%
129,617
$36.61
$4,744,666.50
SELL
17 Nov 2021
MPM BIOVENTURES 2018, L.P.
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
3,073,334
-2%
77,455
$36.61
$2,835,263.00
SELL
1 Nov 2021
Detheux Michel
Chief Executive Officer, Officer
iTeos Therapeutics, Inc.
(ITOS)
76,437
-21%
20,557
$28.55
$586,965.70
SELL
21 Oct 2021
Detheux Michel
Chief Executive Officer, Officer
iTeos Therapeutics, Inc.
(ITOS)
96,994
-0%
196
$28.00
$5,488.02
SELL
15 Oct 2021
MPM BioVentures 2014, L.P.
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
3,134,991
-0%
17,099
$27.45
$469,309.06
SELL
15 Oct 2021
GADICKE ANSBERT
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
5,137,214
-0%
28,615
$27.45
$785,384.40
SELL
15 Oct 2021
Detheux Michel
Chief Executive Officer, Officer
iTeos Therapeutics, Inc.
(ITOS)
97,190
-1%
1,836
$28.01
$51,424.35
SELL
15 Oct 2021
MPM BIOVENTURES 2018, L.P.
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
3,134,991
-0%
17,099
$27.45
$469,309.06
SELL
12 Oct 2021
MPM BioVentures 2014, L.P.
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
3,152,090
-1%
56,770
$27.21
$1,544,473.60
SELL
12 Oct 2021
GADICKE ANSBERT
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
5,165,829
-1%
95,002
$27.21
$2,584,606.00
SELL
12 Oct 2021
MPM BIOVENTURES 2018, L.P.
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
3,152,090
-1%
56,770
$27.21
$1,544,473.60
SELL
7 Oct 2021
MPM BioVentures 2014, L.P.
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
3,208,860
-1%
51,993
$27.23
$1,415,546.20
SELL
7 Oct 2021
GADICKE ANSBERT
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
5,260,831
-1%
87,006
$27.23
$2,368,800.20
SELL
7 Oct 2021
MPM BIOVENTURES 2018, L.P.
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
3,208,860
-1%
51,993
$27.23
$1,415,546.20
SELL
1 Oct 2021
MPM BioVentures 2014, L.P.
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
3,260,853
-0%
27,566
$27.05
$745,524.60
SELL
1 Oct 2021
GADICKE ANSBERT
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
5,347,837
-0%
46,130
$27.05
$1,247,589.50
SELL
1 Oct 2021
MPM BIOVENTURES 2018, L.P.
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
3,260,853
-0%
27,566
$27.05
$745,524.60
SELL
28 Sep 2021
MPM BioVentures 2014, L.P.
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
3,288,419
-0%
21,506
$27.00
$580,662.00
SELL
28 Sep 2021
GADICKE ANSBERT
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
5,393,967
-0%
35,990
$27.00
$971,730.00
SELL
28 Sep 2021
MPM BIOVENTURES 2018, L.P.
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
3,288,419
-0%
21,506
$27.00
$580,662.00
SELL
23 Sep 2021
MPM BioVentures 2014, L.P.
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
3,309,925
-1%
53,468
$27.76
$1,484,415.60
SELL
23 Sep 2021
GADICKE ANSBERT
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
5,429,957
-1%
89,476
$27.76
$2,484,094.00
SELL
23 Sep 2021
Detheux Michel
Chief Executive Officer, Officer
iTeos Therapeutics, Inc.
(ITOS)
99,026
-6%
6,411
$28.14
$180,373.81
SELL
23 Sep 2021
MPM BIOVENTURES 2018, L.P.
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
3,309,925
-1%
53,468
$27.76
$1,484,415.60
SELL
21 Sep 2021
MPM BioVentures 2014, L.P.
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
3,363,393
-0%
33,929
$27.50
$933,030.25
SELL
21 Sep 2021
GADICKE ANSBERT
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
5,519,433
-1%
56,779
$27.50
$1,561,393.60
SELL
21 Sep 2021
MPM BIOVENTURES 2018, L.P.
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
3,363,393
-0%
33,929
$27.50
$933,030.25
SELL
16 Sep 2021
MPM BioVentures 2014, L.P.
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
3,411,023
-2%
91,254
$28.38
$2,590,097.00
SELL
16 Sep 2021
GADICKE ANSBERT
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
5,599,142
-2%
152,711
$28.38
$4,334,451.50
SELL
16 Sep 2021
MPM BIOVENTURES 2018, L.P.
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
3,411,023
-2%
91,254
$28.38
$2,590,097.00
SELL
14 Sep 2021
MPM BioVentures 2014, L.P.
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
3,489,567
-1%
45,665
$27.70
$1,264,909.60
SELL
14 Sep 2021
GADICKE ANSBERT
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
5,730,582
-1%
76,417
$27.70
$2,116,733.00
SELL
14 Sep 2021
MPM BIOVENTURES 2018, L.P.
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
3,489,567
-1%
45,665
$27.70
$1,264,909.60
SELL
9 Sep 2021
MPM BioVentures 2014, L.P.
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
3,534,241
-1%
57,640
$28.32
$1,632,261.50
SELL
9 Sep 2021
GADICKE ANSBERT
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
5,805,340
-1%
96,456
$28.32
$2,731,459.50
SELL
9 Sep 2021
MPM BIOVENTURES 2018, L.P.
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
3,534,241
-1%
57,640
$28.32
$1,632,261.50
SELL
7 Sep 2021
MPM BioVentures 2014, L.P.
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
3,592,821
-1%
42,566
$29.03
$1,235,644.00
SELL
7 Sep 2021
GADICKE ANSBERT
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
5,903,369
-1%
71,232
$29.03
$2,067,786.00
SELL
7 Sep 2021
MPM BIOVENTURES 2018, L.P.
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
3,592,821
-1%
42,566
$29.03
$1,235,644.00
SELL
1 Sep 2021
Detheux Michel
Chief Executive Officer, Officer
iTeos Therapeutics, Inc.
(ITOS)
105,987
-16%
20,252
$28.66
$580,518.00
SELL
27 Aug 2021
Detheux Michel
Chief Executive Officer, Officer
iTeos Therapeutics, Inc.
(ITOS)
125,689
-10%
14,663
$28.13
$412,480.53
SELL
23 Aug 2021
Detheux Michel
Chief Executive Officer, Officer
iTeos Therapeutics, Inc.
(ITOS)
140,352
-5%
8,585
$28.06
$240,889.56
BUY
16 Jun 2021
Gall Matthew
Chief Financial Officer, Officer
iTeos Therapeutics, Inc.
(ITOS)
5,000
+100%
5,000
$26.09
$130,446.50
SELL
14 Jun 2021
Detheux Michel
Chief Executive Officer, Director, Officer
iTeos Therapeutics, Inc.
(ITOS)
152,874
-15%
29,000
$28.50
$826,534.10
SELL
8 Jun 2021
McGrath Yvonne
VP, Research and Development, Officer
iTeos Therapeutics, Inc.
(ITOS)
0
-100%
7,927
$20.00
$158,540.00
SELL
1 Jun 2021
McGrath Yvonne
VP, Research and Development, Officer
iTeos Therapeutics, Inc.
(ITOS)
0
-100%
7,927
$20.17
$159,902.62
SELL
24 May 2021
McGrath Yvonne
VP, Research and Development, Officer
iTeos Therapeutics, Inc.
(ITOS)
0
-100%
7,927
$21.92
$173,796.31
SELL
17 May 2021
McGrath Yvonne
VP, Research and Development, Officer
iTeos Therapeutics, Inc.
(ITOS)
2,119
-78%
7,926
$24.69
$195,719.39
SELL
9 Apr 2021
MPM BioVentures 2014, L.P.
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
3,665,787
-0%
119
$29.99
$3,568.81
SELL
9 Apr 2021
GADICKE ANSBERT
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
6,004,368
-0%
200
$29.99
$5,998.00
SELL
9 Apr 2021
MPM BIOVENTURES 2018, L.P.
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
3,665,787
-0%
119
$29.99
$3,568.81
SELL
7 Apr 2021
MPM BioVentures 2014, L.P.
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
3,666,153
-0%
25,087
$30.99
$777,343.00
SELL
7 Apr 2021
GADICKE ANSBERT
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
6,004,982
-0%
41,982
$30.99
$1,300,850.40
SELL
7 Apr 2021
MPM BIOVENTURES 2018, L.P.
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
3,666,153
-0%
25,087
$30.99
$777,343.00
BUY
28 Jul 2020
MPM BioVentures 2014, L.P.
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
2,083,887
+8%
160,000
$19.00
$3,040,000.00
BUY
28 Jul 2020
MPM BioVentures 2014, L.P.
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
2,083,887
+8%
160,000
$19.00
$3,040,000.00
BUY
28 Jul 2020
Davis Aaron I.
Director, 10% Owner
iTeos Therapeutics, Inc.
(ITOS)
4,345,016
+48%
1,425,000
$19.00
$27,075,000.00
BUY
28 Jul 2020
GADICKE ANSBERT
Director, 10% Owner
iTeos Therapeutics, Inc.
(ITOS)
2,083,887
+18%
320,000
$19.00
$6,080,000.00
BUY
28 Jul 2020
Boxer Capital, LLC
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
4,345,016
+48%
1,425,000
$19.00
$27,075,000.00
BUY
28 Jul 2020
RA CAPITAL MANAGEMENT, L.P.
10% Owner
iTeos Therapeutics, Inc.
(ITOS)
4,417,259
+47%
1,425,000
$19.00
$27,075,000.00
Home